Does hydro-MRI allow on assessment of the activity in Crohn's disease?

被引:25
作者
Schunk, K
Kern, A
Heussel, CP
Kalden, P
Mayer, I
Orth, T
Wanitschke, R
机构
[1] Johannes Gutenberg Univ Mainz, Klin & Poliklin Radiol, D-55131 Mainz, Germany
[2] Univ Mainz Klinikum, Klin & Poliklin Radiol, Mainz, Germany
[3] Univ Mainz Klinikum, Med Klin & Poliklin 1, Mainz, Germany
来源
ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN | 2000年 / 172卷 / 02期
关键词
Crohn's disease; oral bower opacification; hydro MRI; activity; gastrointestinal tract;
D O I
10.1055/s-2000-283
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
To assess the value of hydro-MRI in the assessment of the activity of Crohn's disease. Materials and Methods: after an oral bowel opacification using 1000 ml of a 2,5% mannitol solution, axial and coronal breathhold sequences (T2W HASTE+/-FS, contrast-enhanced T1W FLASH FS) were acquired in 63 patients with Crohn's disease at 1.0T. The enhancement of the bowel wall was correlated with other MRI findings, with the Crohn's disease activity index (CDAI), and the C-reactive protein (CRP). Results: In Crohn's disease, contrast enhancement of the affected bowel wall is markedly increased in comparison with the normal bowel wall (+80+/-23% vs, +43+/-11%; p=8x10(-11)). Positive correlations could be established between the increase of bowel wall enhancement and other MRI findings, Between the increase of bowel wall enhancement and the CDAI a poor correlation was found (r=0.25; p=0.046). There was no statistical correlation between the increase of bowel wall enhancement and the CRP (r=0.09; p=0.24). Conclusion: Hydro-MRI allows an assessment of the activity of Crohn's disease.
引用
收藏
页码:153 / 160
页数:8
相关论文
共 27 条
[1]   Strengths and limitations of the Crohn's disease activity index, revealed by an objective gut lavage test of gastrointestinal protein loss [J].
Acciuffi, S ;
Ghosh, S ;
Ferguson, A .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 (03) :321-326
[2]   MR-IMAGING OF CROHN DISEASE - USE OF PERFLUBRON AS A GASTROINTESTINAL CONTRAST AGENT [J].
ANDERSON, CM ;
BROWN, JJ ;
BALFE, DM ;
HEIKEN, JP ;
BORRELLO, JA ;
CLOUSE, RE ;
PILGRAM, TK .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 1994, 4 (03) :491-496
[3]   ASSESSMENT OF APPROPRIATE LABORATORY MEASUREMENTS TO SUPPLEMENT THE CROHNS-DISEASE ACTIVITY INDEX [J].
ANDRE, C ;
DESCOS, L ;
LANDAIS, P ;
FERMANIAN, J .
GUT, 1981, 22 (07) :571-574
[4]   C-REACTIVE PROTEIN AS A PREDICTOR OF RELAPSE IN ASYMPTOMATIC PATIENTS WITH CROHNS-DISEASE [J].
ANDRE, C ;
DESCOS, L ;
VIGNAL, J ;
GILLON, J .
SCOTTISH MEDICAL JOURNAL, 1983, 28 (01) :25-29
[5]  
BEST WR, 1976, GASTROENTEROLOGY, V70, P439
[6]   Breath-hold fast spin-echo MR imaging of Crohn's disease [J].
Ernst, O ;
Asselah, T ;
Cablan, X ;
Sergent, G .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1998, 170 (01) :127-128
[7]   Surgical treatment of inflammatory bowel diseases [J].
Furst, H ;
Schildberg, FW .
RADIOLOGE, 1998, 38 (01) :8-14
[8]  
GOEBELL H, 1990, MED KLIN, V85, P573
[9]   PELVIC AND PERINEAL COMPLICATIONS OF CROHNS-DISEASE - ASSESSMENT USING MAGNETIC-RESONANCE-IMAGING [J].
HAGGETT, PJ ;
MOORE, NR ;
SHEARMAN, JD ;
TRAVIS, SPL ;
JEWELL, DP ;
MORTENSEN, NJ .
GUT, 1995, 36 (03) :407-410
[10]   Hydro MRI of chronic inflammatory bowel disease. [J].
Hansmann, HJ ;
Kosa, R ;
Dux, M ;
Brado, M ;
Goeser, T ;
Roeren, T ;
Stremmel, W ;
Kauffmann, GW .
ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 1997, 167 (02) :132-138